Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
+1 212 318 2000
Europe, Middle East, & Africa
+44 20 7330 7500
+65 6212 1000
Medicis Pharmaceutical Corp. announced on Friday several personnel changes involving senior executives that become effective July 1.
The Scottsdale, Ariz., drugmaker, which focuses on dermatology, said the changes involve executives who are already with the company, and the moves will position it for future growth and "optimize" the allocation of human resources.
One executive is leaving. Joseph Cooper, executive vice president for corporate and product development, "has decided to pursue career opportunities outside of Medicis" effective June 30, the company said.
Mark Prygocki will become president, a new position. His responsibilities will include human resources, public relations and manufacturing.
Chief Financial Officer Richard Peterson, who also serves as an executive vice president and treasurer, will lead the company's business development and information technology departments.
Jason Hanson will become executive vice president, chief operating officer, and acting general counsel and corporate secretary.
Senior Vice President and Chief Compliance Officer Seth Rodner will be promoted to general counsel and corporate secretary after the appointment of a new chief compliance officer.
The company also said Chief Scientific Officer Mitchell Wortzman will lead the Professional Relations area of the business, which aims to strengthen its relationships with physicians and other health care providers.
Shares of Medicis fell 49 cents, or 2 percent, to $23.20 in Friday afternoon trading.